6-Fluoro-2-methyl-3-(methylsulfonyl)pyridine, 95+%, 500mg

6-Chlorobenzo[d]oxazol-2(3H)-one, 95.0%, 1g

Indol-1-yl-acetic acid, 95.0%, 10g

1-(((4-Nitrophenoxy)carbonyl)oxy)ethyl acetate, 97%, 1g

2-(2,3-dihydro-1,4-benzodioxin-2-yl)ethanol, 95.0%, 10g

4-Fluoropiperidine hydrochloride, 97.0%, 10g

Glass vials with rolled rim brown glass, 40 ml, Height, 80 mm, 200 Piece(s)

N-(2-Aminophenyl)-6-[(7-methoxy-4-quinolinyl)oxy]-1-naphthalenecarboxamide, 95%+, 1g

tert-Butyl 4-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate, 95.0%, 25g

1-(4-Chlorobenzyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 5g

3a-(2-Chlorophenyl)-3a,4,5,6-tetrahydrobenzo[d]oxazol-2(3H)-one, 5mg

4-(2,5-Dioxo-2,5-dihydropyrrol-1-yl)-benzoic acid, 96.0%, 25g

4-Methoxy-3-nitrotoluene>98.0%(GC)25g